Yazar "Baykan, B." için listeleme
-
Do the neurologists recognize autoimmune epilepsy well enough? What is the effect of the pandemic on this matter?
Yavuz, E.N.V.; Altındağ, E.; Tüzün, E.; Baykan, B. (Springer-Verlag Italia s.r.l., 2022)Introduction: The concept of “autoimmune epilepsy” (AE) has been emphasized more frequently through the recent increase in recognition of various autoantibodies specific to neuronal proteins. Aims: To evaluate the attitudes ... -
Electrografic seizures and periodic epileptiform discharges in patients with postanoxic coma
Altındağ, E.; Okudan, Z.V.; Baykan, B.; Tuncer, O.G.; Koyuncu, B. A.; Özkan, S.T.; Krespi, Y. (Wiley-Blackwell, 2012)Purpose: We aimed to examine the predictors and prognostic value of electrographic seizures (ESZs) and periodic epileptiform discharges (PED) of post-anoxic coma patients in intensive care unit (ICU). -
Long-term follow-up of genetic generalized epilepsy with typical absence seizures and generalized paroxysmal fast activity in adulthood
Özemir, Z. Aydın; Matur, Zeliha; Bebek, Nerses; Gürses, R. Candan; Gokyigit, A.; Baykan, B. (Wiley, 2014)Introduction: Generalized paroxysmal fast activity (GPFA), a rhythmic EEG pattern of unknown significance was reported in a few patients with genetic generalized epilepsy (GGE) presenting with typical absence seizures ... -
MR spectroscopy findings in lafora disease: Short communication
Altindag, E.; Kara, B.; Baykan, B.; Terzibasioglu, E.; Sencer, S.; Onat, L.; Si, M. (2009)Our aim was to investigate the [1H] MR spectroscopy (MRS) findings of Lafora Disease (LD), which is a disabling form of progressive myoclonic epilepsy. METHODS Twelve patients diagnosed with LD and 12 control subjects ...